Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
ACS Omega ; 4(6): 9823-9827, 2019 Jun 30.
Article in English | MEDLINE | ID: mdl-31460072

ABSTRACT

A facile approach was developed to produce MoS2 nanosheets by ultrasound-assisted reflux exfoliation, which was highly efficient for large-scale production and sustainable for environment. The interlayer force of bulk MoS2 was first exhausted in employing LiOH/NaOH solution by reflux and thereafter quickly exfoliated by ultrasound. The lateral size of the as-prepared MoS2 nanosheets with about 2-9 layers became smaller. Definitely, the average friction coefficient and wear scar diameter of 0.08 wt % MoS2-based oil decreased by about 21.87 and 38.09% relative to the base oil, which displayed better antifriction and antiwear performances.

2.
RSC Adv ; 9(30): 17016-17024, 2019 May 29.
Article in English | MEDLINE | ID: mdl-35519880

ABSTRACT

The exfoliation of bulk MoS2 into few layers has attracted considerable attention as 2D nanomaterials in the past decade. We developed a facile approach for producing MoS2 nanosheets by hydrothermal-assisted shearing exfoliation based on organic-free strategy. This original exfoliation was highly efficient for large-scale production and sustainable for the environment. The thickness of the as-exfoliated MoS2 nanosheets was about 4-6 layers, and the lateral size became smaller from hydrothermal processing to shearing. The hydrothermal processing with the participation of ammonium carbonate played an important role in hydrothermal-assisted shearing exfoliation. As a prospective application, the antifriction performance of the as-exfoliated MoS2 nanosheets in oil was evaluated using a ball-on-ball mode. Evidently, the average friction coefficient and wear scar diameter of 0.08 wt% MoS2-based oil dropped to about 20.66% and 47.27% relative to those of the base oil, which exhibited an excellent antifriction and antiwear ability.

3.
Oncotarget ; 9(9): 8629-8641, 2018 Feb 02.
Article in English | MEDLINE | ID: mdl-29492222

ABSTRACT

Caspase-3 is a vital executioner molecule during the apoptotic process. Numerous studies have revealed the close association of caspase-3 expression and breast cancer. Nevertheless, the prognostic value of caspase-3 expression for patients with breast cancer remains uncertain. To thoroughly analyze the prognostic effect of caspase-3 expression on the clinicopathological features and survival of breast cancer, we conducted this meta-analysis. With various search strategies, electronic databases were comprehensively searched. A total of 3091 patients from 21 studies were ultimately obtained. The analysis results indicated that increased expression of caspase-3 had a negative influence on the overall survival (OS) of breast cancer (HR = 1.73, 95%CI 1.12-2.67, P = 0.014). Subgroup analyses based on race revealed that the value of caspase-3 for evaluating patients' OS was more useful in Asian patients (HR = 3.16, 95%CI 1.20-8.15, P = 0.020), and subgroup analyses based on study analytical methods revealed that caspase-3 was a risk factor for breast cancer patients in multivariate overall survival analyses (HR = 1.67, 95%CI 1.02-2.75, P = 0.044). As for the relationship between caspase-3 expression and breast cancer subtype as well as progression, caspase-3 might serve as a risk factor for the progestogen receptor (PR) and human epidermal growth factor receptor-2 (HER-2) subtypes (OR = 1.44, 95%CI 1.09-1.89, P = 0.010; OR = 1.76, 95%CI 1.18-2.62, P = 0.050, respectively) of breast cancer. However, no evidence showed that increased expression of caspase-3 was statistically correlated with tumor differentiation state (low/moderate or high), tumor TNM stage (I-II/III-IV) or lymph node metastasis (-/+). In conclusion, this meta-analysis revealed that increased caspase-3 expression was significantly associated with worse prognosis and two subtypes of breast cancer. More prospective studies are urgently needed to define the prognostic value of caspase-3 expression in patients with breast cancer.

4.
Int J Mol Med ; 41(5): 2813-2831, 2018 May.
Article in English | MEDLINE | ID: mdl-29484429

ABSTRACT

Mounting evidence has shown that miR-23b-3p, which is associated with cell proliferation, invasion, and apoptosis, acts as a biomarker for diagnosis and outcomes in numerous cancers. However, the clinicopathological implication of miR-23b-3p in hepatocellular carcinoma (HCC) remains unclear. Our study evaluated the role of miR-23b-3p in HCC and investigated its potential application as a marker for preliminary diagnosis and therapy in HCC. High-throughput data from the NCBI Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) were collected and analyzed. One hundred and one tissue sections of HCC were paired with adjacent non-cancerous HCC as further supplements. miR-23b-3p expression was detected using quantitative real-time PCR. Additionally, the relationship between miR-23b-3p expression and HCC progression and Time-to-recurrence (months) was explored. Ten algorithms were applied to predict the prospective target genes of miR-23b-3p. Next, we conducted bioinformatics analysis for further study. miR-23b-3p expression was pronouncedly decreased in HCC tissues in contrast with their paired adjacent non-cancerous HCC (P<0.001) with RT-qPCR. In total, 405 targets, acquired with consistent prediction from at least five databases, were used for the bioinformatics analysis. According to the Gene Ontology (GO) analysis, all targets were classified into biological processes, cellular components and molecular functions. In the pathway analysis, targets of miR-23b-3p were primarily enriched in the signaling pathways of renal cell carcinoma, hepatitis B and pancreatic cancer (corrected P-value <0.05). In the protein-protein interaction (PPI) network for miR-23b-3p, a total of 8 targets, including SRC, AKT1, EGFR, CTNNB1, BCL2, SMAD3, PTEN and KDM6A, were located in the key nodes with high degree (>35). In conclusion, this study provides impressive illumination of the potential role of miR-23b-3p in HCC tumorigenesis and progression. Furthermore, miR-23b-3p may act as a predictor of HCC and could be a new treatment target.


Subject(s)
Carcinoma, Hepatocellular/genetics , Down-Regulation , Gene Expression Regulation, Neoplastic , Liver Neoplasms/genetics , MicroRNAs/genetics , Carcinoma, Hepatocellular/diagnosis , Carcinoma, Hepatocellular/pathology , Disease Progression , Female , Gene Regulatory Networks , Humans , Liver/metabolism , Liver/pathology , Liver Neoplasms/diagnosis , Liver Neoplasms/pathology , Male , Middle Aged , Real-Time Polymerase Chain Reaction , Transcriptome
5.
ACS Omega ; 3(11): 15002-15008, 2018 Nov 30.
Article in English | MEDLINE | ID: mdl-31458166

ABSTRACT

One-dimensional MoS2 nanotubes with the specific surface area of 89.34 m2/g and the average pore size of 2.52 nm were successfully synthesized by the thermolytical approach assisted by halloysite nanotubes. The tribological properties of MoS2 nanotubes with good dispersion in oil were tested with a four-ball wear tester. The tribological testing results indicated that the average friction coefficient and the average wear scar diameter of the 0.08 wt % MoS2-based oil at 25 °C decreased about 39.2 and 35.0%, respectively, compared to those of the 150 SN base oil, indicating that the as-prepared MoS2 nanotubes as a lubricating additive can enhance the tribological performances. Finally, the lubrication mechanism of MoS2 nanotubes was put forward.

6.
Oncotarget ; 8(62): 104960-104980, 2017 Dec 01.
Article in English | MEDLINE | ID: mdl-29285225

ABSTRACT

PURPOSE: The prognostic role of miR-204-5p (previous ID: miR-204) is varied and inconclusive in diverse types of malignant neoplasm. Therefore, the purposes of the study comprehensively explore the overall prognostic role of miR-204-5p based on high-throughput microRNA sequencing data, and to investigate the potential role of miR-204-5p via bioinformatics approaches. MATERIALS AND METHODS: The data of microRNA sequencing and survival were downloaded from The Cancer Genome Atlas (TCGA), and the prognostic value of miR-204-5p was analyzed by using Kaplan-Meier and univariate cox regressions. Then a meta-analysis was conducted with all TCGA data and relevant studies collected from literature. Pooled hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated. The prospective molecular mechanism of miR-204-5p was also assessed at a functional level with Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and protein-to-protein interactions (PPI) network. RESULTS: From TCGA data, the prognostic value of miR-204-5p obviously varied among 20 types of cancers. The pooled HR was 0.928 (95% CI: 0.774-1.113, P = 0.386, 6203 cases of malignancies). For the meta-analysis based on 15 studies from literature, the pooled HR was 0.420 (95% CI: 0.306-0.576, P < 0.001, 1783 cases of malignancies) for overall survival (OS). Furthermore, the combined HR from both TCGA and literature was 0.708 (95% CI: 0.600-0.834, P < 0.001, 7986 cases of malignancies). Subgroup analyses revealed that miR-204-5p could act as a prognostic marker in cancers of respiratory system and digestive system. Functional analysis was conducted on genes predicted as targets (n = 2057) after the overlay genes from six out of twelve software were extracted. Two significant KEGG pathways were enriched (hsa04360: Axon guidance and hsa04722: Neurotrophin signaling pathway). PPI network revealed some hub genes/proteins (CDC42, SOS1, PIK3R1, MAPK1, PLCG1, ESR1, MAPK11, and AR). CONCLUSIONS: The current study demonstrates that over-expression of miR-204-5p could be a protective factor for a certain group of cancers. Clinically, the low miR-204-5p level could gain a predictive value for a poor survival in cancers of respiratory system and digestive system. The detailed molecular mechanisms of miR-204-5p remain to be verified.

7.
J Back Musculoskelet Rehabil ; 30(4): 725-733, 2017.
Article in English | MEDLINE | ID: mdl-28282792

ABSTRACT

BACKGROUND: Little is known about the effects of Kinesio taping and therapeutic exercise on correcting forward head posture. OBJECTIVE: To compare Kinesio taping versus therapeutic exercise for forward head posture on static posture, dynamic mobility and functional outcomes. METHODS: Sixty subjects (31 women, 29 men) with forward head postures participated in this study. They were randomly assigned to either one of the three groups: (1) exercise group (n = 20), (2) taping group (n = 20), and (3) control groups (n = 20). The horizontal forward displacement (HFD) between ear lobe and acromion process, upper cervical and lower cervical angle (UCA, LCA), active range of motion (AROM) of cervical spine, and neck disability index (NDI) were measured before and after a 5-week intervention, and a 2-week follow-up. Data were analyzed by means of a mixed design repeated-measures ANOVA. RESULTS: Both taping and exercise groups showed significant improvements in HFD compared with the control group at post-treatment and follow-up. Compared with the control group, the exercise group exhibited significant improvements in the LCA and the side bending AROM at post-treatment. CONCLUSIONS: Both Kinesio taping and therapeutic exercise improve forward head posture after intervention and a 2-week follow-up. The effectiveness of therapeutic exercise is better than taping.


Subject(s)
Athletic Tape , Cervical Vertebrae/physiology , Exercise Therapy , Posture , Adult , Exercise , Female , Humans , Male , Prospective Studies , Range of Motion, Articular , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...